Losartan potassium and Fludrocortisone acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Losartan potassium (losartan potassium) and Fludrocortisone acetate (fludrocortisone acetate). Common drug interactions include erythema among females and dyspepsia among males.

The phase IV clinical study analyzes what interactions people have when they take Losartan potassium and Fludrocortisone acetate. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,513 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Fludrocortisone acetate?

Fludrocortisone acetate has active ingredients of fludrocortisone acetate. It is often used in hypotension. eHealthMe is studying from 2,859 Fludrocortisone acetate users. Check the latest studies of Fludrocortisone acetate.



On Aug, 09, 2026

30 people who take Losartan potassium and Fludrocortisone acetate together, and have interactions are studied.

Losartan potassium and Fludrocortisone acetate drug interactions.

What are the common drug interactions of Losartan Potassium and Fludrocortisone Acetate, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Cough
  3. Fall
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Sinusitis (inflammation of sinus)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Constipation
  8. Pain
  9. Pruritus (severe itching of the skin)
  10. Skin swelling

male:

  1. Dyspepsia (indigestion)
  2. Asthma
  3. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  4. Dry eye (lack of adequate tears)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hepatic enzyme increased
  7. Hepatic steatosis (fatty liver disease)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Multiple system atrophy (degeneration of nerve cells in specific areas of the brain)
  10. Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Losartan Potassium and Fludrocortisone Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Headache (pain in head)
  2. Pain
  3. Pyrexia (fever)
  4. Rash
  5. Sluggishness (lacking alertness)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Social phobia (fear to go in social)
  2. Type 2 diabetes mellitus
  3. Urinary retention (the inability to completely or partially empty the bladder)
  4. Urinary tract infection
  5. Vomiting
  6. Asthma
  7. Ataxia (loss of full control of bodily movements)
  8. Blood cholesterol increased
  9. Bruxism (habitual grinding of the teeth, typically during sleep)
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

60+:

  1. Erythema (redness of the skin)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  4. Diarrhoea
  5. Disease progression
  6. Loss of consciousness
  7. Oedema peripheral (superficial swelling)
  8. Pleural effusion (water on the lungs)
  9. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  10. Viral infection

What are the existing conditions these people have? *

  1. Hyperkalemia (damage to or disease of the kidney): 9 people, 30.00%
  2. Stress And Anxiety: 3 people, 10.00%
  3. Renal Cell Carcinoma (a kidney cancer): 3 people, 10.00%
  4. Multiple Myeloma (cancer of the plasma cells): 3 people, 10.00%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 10.00%
  6. Vitamin B6 Deficiency: 2 people, 6.67%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
  8. Parkinson's Disease: 2 people, 6.67%
  9. Pain: 2 people, 6.67%
  10. Indigestion: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and Fludrocortisone acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Losartan potassium and Fludrocortisone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fludrocortisone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Losartan potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fludrocortisone acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and fludrocortisone acetate (the active ingredients of Losartan potassium and Fludrocortisone acetate, respectively), and Losartan potassium and Fludrocortisone acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: